Is ENCW or JNJ a better dividend investment in 2026?

ENCW currently yields 666666.67% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: ENCW offers higher current income.

What is the dividend yield difference between ENCW and JNJ?

ENCW has a forward dividend yield of 666666.67% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 666664.54 percentage points.

Home › Compare › ENCW vs JNJ

ENCW vs JNJ: Dividend Comparison 2026

ENCW yields 666666.67% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ENCW wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ENCW

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full ENCW calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — ENCW vs JNJ

📍 ENCW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ENCW	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ENCW + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ENCW pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENCW

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, ENCW beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENCW + JNJ for your $10,000?

ENCW: 50%JNJ: 50%

100% JNJ50/50100% ENCW

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ENCW

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENCW buys

JNJ buys

No recent congressional trades found for ENCW or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricENCWJNJ

Forward yield	666666.67% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$8.275235618773884e+34M	$30.3K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$8.275075881065991e+34M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ENCW vs JNJ ($10,000, DRIP)

Year	ENCW Portfolio	ENCW Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$10,592	$272.30	+$66.67M → ENCW
2	$415,506,651,117	$415,435,306,334.37	$11,289	$357.73	+$415506.64M → ENCW
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$12,123	$472.89	+$2419908598.37M → ENCW
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$13,141	$629.86	+$13171697643084.44M → ENCW
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$14,408	$846.81	+$67004927492790120.00M → ENCW
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$16,021	$1,151.60	+$318562277003514871808.00M → ENCW
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$18,122	$1,588.22	+$1.415484168853553e+24M → ENCW
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$20,930	$2,228.20	+$5.878130573362507e+27M → ENCW
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$2.2813793009840744e+31M → ENCW
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$8.275235618773884e+34M → ENCW

ENCW vs JNJ: Complete Analysis 2026

ENCW — Stock

Enchanted World Inc. engages in the development, manufacture, and distribution of health care products in the United States. The company offers fitness and weight loss equipment and products. The company offers BioFit infrared bike, a design for the use of infrared and exercise to reduce body fat. The BioFit engages 3,300 watts of infrared lights and offers detox, inch loss, weight loss, inflammation reduction, pain control, and enhanced calorie burn. It provides its products to wellness and weight loss centers, med spas, gyms, doctors' offices, and day spas. The company was formerly known as Cardio Infrared Technologies, Inc. and changed its name to Enchanted World Inc. in December 2014. Enchanted World Inc. is based in Henderson, Nevada.

Full ENCW Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ENCW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENCW vs SCHD ENCW vs JEPI ENCW vs O ENCW vs KO ENCW vs MAIN ENCW vs ABBV ENCW vs MRK ENCW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.